Treatment of rheumatoid arthritis in patients with concomitant chronic hepatitis C infection

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Hepatitis C virus (HCV) infection is present in 1.8% of the general US population and its prevalence worldwide is estimated at 2–3%. HCV infected patients with concomitant rheumatoid arthritis (RA) pose a particular challenge to the rheumatologist because of the risks of treatment with disease-modifying medications in patients with chronic liver infection. In this paper the difficulties of diagnosing RA in HCV patients and the safety of RA treatment in patients with both conditions are discussed.

Original languageEnglish
Pages (from-to)35-40
Number of pages6
JournalTherapeutic Advances in Musculoskeletal Disease
Volume4
Issue number1
DOIs
StatePublished - Feb 2012

Keywords

  • biological-response modifiers
  • disease-modifying antirheumatic drugs
  • hepatitis C
  • rheumatoid arthritis

Fingerprint Dive into the research topics of 'Treatment of rheumatoid arthritis in patients with concomitant chronic hepatitis C infection'. Together they form a unique fingerprint.

  • Cite this